OptiNose Statistics
Total Valuation
OptiNose has a market cap or net worth of $153.53 million. The enterprise value is $232.54 million.
| Market Cap | 153.53M |
| Enterprise Value | 232.54M |
Important Dates
The next estimated earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OptiNose has 144.84 million shares outstanding. The number of shares has increased by 0.73% in one year.
| Shares Outstanding | 144.84M |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 6.25% |
| Owned by Institutions (%) | 61.64% |
| Float | 81.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.07 |
| Forward PS | 1.48 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.48
| Current Ratio | 2.48 |
| Quick Ratio | 2.01 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.55 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -30.80% |
| Return on Capital (ROIC) | -52.34% |
| Revenue Per Employee | $560,773 |
| Profits Per Employee | -$232,992 |
| Employee Count | 132 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 0.88 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -0.12 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.13 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 44.72 |
| Average Volume (20 Days) | 1,288,606 |
Short Selling Information
The latest short interest is 7.72 million, so 5.33% of the outstanding shares have been sold short.
| Short Interest | 7.72M |
| Short Previous Month | 5.70M |
| Short % of Shares Out | 5.33% |
| Short % of Float | 9.43% |
| Short Ratio (days to cover) | 7.49 |
Income Statement
In the last 12 months, OptiNose had revenue of $74.02 million and -$30.76 million in losses. Loss per share was -$0.27.
| Revenue | 74.02M |
| Gross Profit | 65.86M |
| Operating Income | -16.45M |
| Pretax Income | -30.76M |
| Net Income | -30.76M |
| EBITDA | -10.52M |
| EBIT | -10.93M |
| Loss Per Share | -$0.27 |
Balance Sheet
The company has $51.64 million in cash and $130.65 million in debt, giving a net cash position of -$79.01 million or -$0.55 per share.
| Cash & Cash Equivalents | 51.64M |
| Total Debt | 130.65M |
| Net Cash | -79.01M |
| Net Cash Per Share | -$0.55 |
| Equity (Book Value) | -99.22M |
| Book Value Per Share | -0.69 |
| Working Capital | 48.42M |
Cash Flow
In the last 12 months, operating cash flow was -$32.08 million and capital expenditures -$350,000, giving a free cash flow of -$32.43 million.
| Operating Cash Flow | -32.08M |
| Capital Expenditures | -350,000 |
| Free Cash Flow | -32.43M |
| FCF Per Share | -$0.29 |
Margins
Gross margin is 88.98%, with operating and profit margins of -22.23% and -41.55%.
| Gross Margin | 88.98% |
| Operating Margin | -22.23% |
| Pretax Margin | -41.55% |
| Profit Margin | -41.55% |
| EBITDA Margin | -14.21% |
| EBIT Margin | -14.76% |
| FCF Margin | -43.81% |
Dividends & Yields
OptiNose does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.73% |
| Earnings Yield | -20.03% |
| FCF Yield | -21.12% |
Analyst Forecast
The average price target for OptiNose is $3.67, which is 246.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.67 |
| Price Target Difference | 246.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 37.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OptiNose has an Altman Z-Score of -10.63 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.63 |
| Piotroski F-Score | 3 |